Donegan Michael C
Prin. Fin. and Acctg. Officer at TXMD
- Sold, on record
- $41k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Jan 27, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TXMDTherapeuticsMD, Inc.Prin. Fin. and Acctg. Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TXMDUnusualMay 11, 2021 2021
Sold 4,842 shares at $1.04 ($5k)
Donegan Michael C, CAO and VP Finance
Sold 25.5% of holdings ($20k position)14,158 shares leftFirst sale on recordFiling
- 2 Form 4 sale TXMDPlan not statedNov 30, 2021 +203 days
Sold 29,790 shares at $0.54 ($16k)
Donegan Michael C, CAO and VP of Finance
Sold 23.1% of holdings ($70k position)99,368 shares leftFiling
- 3 Form 4 sale TXMDPlan not statedDec 6, 2022 +371 days
Sold 910 shares at $4.78 ($4k)
Donegan Michael C, Interim CFO/CAO/VP of Finance
Sold 16.7% of holdings ($26k position)4,554 shares leftFiling
- 4 Form 4 sale TXMDPlan not statedJan 24, 2023 +49 days
Sold 1,309 shares at $5.34 ($7k)
Donegan Michael C, Prin. Fin. and Acctg. Officer
Sold 14.7% of holdings ($48k position)7,610 shares left0.3x usual sizeFiling
- 5 Form 4 sale TXMDPlan not statedJan 27, 2023 +3 days
Sold 1,697 shares at $5.08 ($9k)
Donegan Michael C, Prin. Fin. and Acctg. Officer
Sold 12.5% of holdings ($69k position)11,853 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | Jan 30, 2023 | TXMD | Prin. Fin. and Acctg. Officer | Form 4 sale | 1,697 | $9k | 12.5% | Plan not stated | SEC |
| Jan 24, 2023 | Jan 25, 2023 | TXMD | Prin. Fin. and Acctg. Officer | Form 4 sale | 1,309 | $7k | 14.7% | Plan not stated | SEC |
| Dec 6, 2022 | Dec 9, 2022 | TXMD | Interim CFO/CAO/VP of Finance | Form 4 sale | 910 | $4k | 16.7% | Plan not stated | SEC |
| Nov 30, 2021 | Dec 2, 2021 | TXMD | CAO and VP of Finance | Form 4 sale | 29,790 | $16k | 23.1% | Plan not stated | SEC |
| May 11, 2021 | May 12, 2021 | TXMD | CAO and VP Finance | Form 4 sale | 4,842 | $5k | 25.5% | Unusual | SEC |